ObjectiveTo find the role of oncogene cmet and suppressor gene p53 in the process of tumor angiogenesis and their clinical significance. MethodsBy immunohistochemical method and computer image analysis technique, microvessel count and cmet, p53 protein expression were quantitatively determined in 80 cases of breast carcinoma and 20 cases of breast fibroadenoma. ResultsThe high microvessel count and the positive expression of cmet, p53 were significantly correlated with histologic grade, lymph node metastasis and the stage of the tumor (P＜0.01). The high microvessel count was significantly correlated with the positive expression of cmet and p53 (P＜0.01).ConclusionBoth oncogene cmet and suppressor gene p53 modulate tumor angiogenesis of breast carcinoma.
Citation：
YIN Jiajun,SONG Yan,WANG Xiaobo,et al.. Relationship Between cmet, p53 Expression in Breast Carcinoma and Tumor Angiogenesis. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2002, 9(5): 316-318. doi:
Copy
Copyright © the editorial department of CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY of West China Medical Publisher. All rights reserved
| 1. |
Bosari S, Lee AK, DeLellis RA, et al. Microvessel quantitation and prognosis in invasive breast carcinoma [J]. Hum Pathol, 1992; 23(7)∶755.
|
| 2. |
Weidner N, Folkman J, Pozza F, et al . Tumor angiogenesis: a new significant and independent prognostic indicator in earlystage breast carcinoma [J]. J Natl Cancer Inst, 1992; 84(24)∶1875.
|
| 3. |
Jin L, Fuchs A, Schnitt SJ, et al. Expression of scatter factor and cmet receptor in benign and malignant breast tissue [J]. Cancer, 1997; 79(4)∶749.
|
| 4. |
Hollstein M, Sidransky K, Vogelstein B, et al. p53 mutations in human cancers [J]. Science, 1991; 253(5015)∶49.
|
| 5. |
Levine AJ, Perry ME, Chang A, et al. The 1993 Walter Hubert Lecture: the role of the p53 tumoursuppressor gene in tumorigenesis [J]. Br J Cancer, 1994; 69(3)∶409.
|
| 6. |
Grant DS, Kleinman HK, Goldberg ID, et al. Scatter factor induces blood vessel formation in vivo [J].Proc Natl Acad Sci U S A, 1993; 90(5)∶1937.
|
| 7. |
Xu M, Kumar D, Srinivas S, et al. Parenteral gene therapy with p53 inhibits human breast tumors in vivo through a bystander mechanism without evidence of toxicity [J]. Hum Gene Ther, 1997; 8(2)∶177.
|
- 1. Bosari S, Lee AK, DeLellis RA, et al. Microvessel quantitation and prognosis in invasive breast carcinoma [J]. Hum Pathol, 1992; 23(7)∶755.
- 2. Weidner N, Folkman J, Pozza F, et al . Tumor angiogenesis: a new significant and independent prognostic indicator in earlystage breast carcinoma [J]. J Natl Cancer Inst, 1992; 84(24)∶1875.
- 3. Jin L, Fuchs A, Schnitt SJ, et al. Expression of scatter factor and cmet receptor in benign and malignant breast tissue [J]. Cancer, 1997; 79(4)∶749.
- 4. Hollstein M, Sidransky K, Vogelstein B, et al. p53 mutations in human cancers [J]. Science, 1991; 253(5015)∶49.
- 5. Levine AJ, Perry ME, Chang A, et al. The 1993 Walter Hubert Lecture: the role of the p53 tumoursuppressor gene in tumorigenesis [J]. Br J Cancer, 1994; 69(3)∶409.
- 6. Grant DS, Kleinman HK, Goldberg ID, et al. Scatter factor induces blood vessel formation in vivo [J].Proc Natl Acad Sci U S A, 1993; 90(5)∶1937.
- 7. Xu M, Kumar D, Srinivas S, et al. Parenteral gene therapy with p53 inhibits human breast tumors in vivo through a bystander mechanism without evidence of toxicity [J]. Hum Gene Ther, 1997; 8(2)∶177.
